182
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Validation of NAD synthase inhibitors for inhibiting the cell viability of Leishmania donovani: In silico and in vitro approach

, ORCID Icon, , &
Pages 4481-4493 | Received 17 Jul 2018, Accepted 16 Nov 2018, Published online: 19 Jan 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Shalini Yadav, Haraprasad Mandal, Vijayakumar Saravanan, Pradeep Das & Shubhankar Kumar Singh. (2021) In vitro and in silico analysis of L. donovani enoyl acyl carrier protein reductase - A possible drug target. Journal of Biomolecular Structure and Dynamics 39:16, pages 6056-6069.
Read now
Clauber Henrique Souza da Costa, Ted Wilson Bichara, Guelber Cardoso Gomes, Alberto Monteiro dos Santos, Kauê Santana da Costa, Anderson Henrique Lima e Lima, Cláudio Nahum Alves & Jerônimo Lameira. (2021) Unraveling the conformational dynamics of glycerol 3-phosphate dehydrogenase, a nicotinamide adenine dinucleotide-dependent enzyme of Leishmania mexicana. Journal of Biomolecular Structure and Dynamics 39:6, pages 2044-2055.
Read now

Articles from other publishers (2)

Obinna Markraphael Ajunwa, Olubusola Ayoola Odeniyi, Emmanuel Oluwaseun Garuba, Mrinalini Nair, Enrico Marsili & Abiodun Anthony Onilude. (2022) Evaluation of extracellular electron transfer in Pseudomonas aeruginosa by co-expression of intermediate genes in NAD synthetase production pathway. World Journal of Microbiology and Biotechnology 38:5.
Crossref
Kyle H. Rohde & Leonardo Sorci. (2021) The Prospective Synergy of Antitubercular Drugs With NAD Biosynthesis Inhibitors. Frontiers in Microbiology 11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.